A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)
Abroad (travel likely)RecruitingPHASE2
Conditions
Eczema Atopic Dermatitis · Eczema · Atopic Dermatitis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
ALS Global, Irving, Texas, United States